A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer
Acta Pharmacologica Sinica2017Vol. 38(6), pp. 931–942
Citations Over Time
Xin-shuai Wang, De-jiu Kong, Tzu‐yin Lin, Xiao-cen Li, Yoshihiro Izumiya, Xue-zhen Ding, Li Zhang, Xiao-chen Hu, Jun-qiang Yang, She-gan Gao, Kit S. Lam, Yuanpei Li
Related Papers
- → Inter-patient variability in docetaxel pharmacokinetics: A review(2015)46 cited
- Docetaxel (Taxotere): preclinical and general clinical information.(1999)
- → Docetaxel (Taxotere) in the Treatment of Non-Small Cell Lung Cancer(2002)18 cited
- Docetaxel enhances the cytotoxicity of tetrahydropyranyladriamycin in a sequence-dependent manner.(2001)
- TS-1 による術後補助療法中に発症しWeekly Docetaxel 療法により著効をみた胃癌腹膜播種の1 例(2005)